Replies to post #347833 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

His numbers seem pretty on point to me. Lets see what our trial results are and if the FDA cuts us any slack on phase 3 before you poo poo $10.

No EUA and not partner/buyout means massive dilution with no guarantee of COVID revenues in 2023 when we get approval.

Elimination of risk is a huge positive of a buyout that you cant discount too heavily in our position.

Go IPIX!

[Empiricst1]

"Wow... you have a lot of homework to do if you think that Leo would take 5-10 per share."

An offer at the $5-10 or more level would imply a combination of at least 2 or more successful Ph 3s e.g. for example in B for Covid, OM, ABSSSI, the N. Italian trial, or even Kevetrin, etc. I've firmly believed that IPIX will get at least one, and maybe (yes, maybe) more successes. Just one and we all come home, more and the big money follows. But the odds on this all happening are high, high. We shouldn't kid ourselves. And if a rolling thunder occurs with one successful trial providing money for the next, etc. we are still talking in terms of years, not months, and Leo (and a lot of us here) ain't no kids. GLTY